One of the key challenges in studying MET is its dynamic and reversible nature, which makes it difficult to capture and analyze in real-time. Additionally, the interplay between EMT and MET is highly context-dependent, varying between different cancer types and stages. Advanced techniques in single-cell sequencing and live-cell imaging are helping to overcome these challenges, providing deeper insights into these complex processes.
